TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32731981

Group type: EXPERIMENTAL
Intervention: Enzyme hydrolysate gross energy (EHGE) in mixed diets
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: Enzyme hydrolysate gross energy (EHGE) in experimental diets
Number of subjects: 384

Group type: EXPERIMENTAL
Intervention: EHGE requirement for ducks from hatch to 21 days of age
Number of subjects: 384
Study: 36396068

Group type: EXPERIMENTAL
Intervention: AIM2ACT mobile health intervention (n = 80)
Number of subjects: 160

Group type: COMPARATOR
Intervention: mHealth attention control condition (n = 80)
Number of subjects: 160
Study: 33129818

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs)
Number of subjects: 403

Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKAs)
Number of subjects: 403
Study: 35139723

Group type: EXPERIMENTAL
Intervention: Postural correction exercises
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Spinal mobilization
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 32193775

Group type: EXPERIMENTAL
Intervention: I-F (Cryoablation with CPVI and additional substrate modification by radiofrequency ablation)
Number of subjects: 90

Group type: COMPARATOR
Intervention: RF (Radiofrequency ablation with CPVI and additional substrate modification)
Number of subjects: 90
Study: 33139537

Group type: COMPARATOR
Intervention: Subcutaneous BFKB8488A injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34417396

Group type: EXPERIMENTAL
Intervention: 40U DaxibotulinumtoxinA (DAXI) treatment
Number of subjects: 568
Study: 32462341

Group type: EXPERIMENTAL
Intervention: IO retroequatorial myopexy
Number of subjects: 40

Group type: COMPARATOR
Intervention: IO myectomy
Number of subjects: 40
Study: 35953872

Group type: EXPERIMENTAL
Intervention: Single dose of intravenous cefazolin (1 g)
Number of subjects: 364

Group type: COMPARATOR
Intervention: No antibiotic prophylaxis
Number of subjects: 364
Study: 33340496

Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 136

Group type: COMPARATOR
Intervention: Inert auricular placebo patches
Number of subjects: 136
Study: 35104873

Group type: EXPERIMENTAL
Intervention: Analytical treatment interruptions (ATI)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 33135286

Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education plus Motor Control Exercises (PNE + MCE)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Group-Based Exercise (GE)
Number of subjects: 73
Study: 33031838

Group type: EXPERIMENTAL
Intervention: LP-Nd:YAG laser
Number of subjects: 150
Study: 33407719

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine plus ketamine (ketodex)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous ketamine
Number of subjects: 0
Study: 36329796

Group type: EXPERIMENTAL
Intervention: Informed Health Choices (IHC) learning resources
Number of subjects: 0
Study: 33196487

Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 2934

Group type: COMPARATOR
Intervention: Sublobar resection
Number of subjects: 2934
Study: 35710437

Group type: COMPARATOR
Intervention: Usual Care-Plus
Number of subjects: 246

Group type: COMPARATOR
Intervention: VERSE
Number of subjects: 246

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 246
Study: 32200827

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (topical prednisolone phosphate)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 35452873

Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet
Number of subjects: 219
Study: 34041968

Group type: EXPERIMENTAL
Intervention: Freeze-dried bone allograft combined with autograft (Group 1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Freeze-dried bone allograft alone (Group 2)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 20
Study: 32023184

Group type: EXPERIMENTAL
Intervention: Eccentric cycling with blood flow restriction (ECCBFR)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Eccentric cycling (ECC)
Number of subjects: 21
Study: 35623879

Group type: EXPERIMENTAL
Intervention: NaBut
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 33190372

Group type: EXPERIMENTAL
Intervention: DHA-containing camouflage
Number of subjects: 30

Group type: COMPARATOR
Intervention: Blank group (control)
Number of subjects: 30
Study: 33070235

Group type: EXPERIMENTAL
Intervention: ACD
Number of subjects: 554

Group type: COMPARATOR
Intervention: Control
Number of subjects: 554
Study: 32687804

Group type: EXPERIMENTAL
Intervention: BPZE1 vaccine (107, 108, and 109 CFU doses)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: BPZE1 vaccine (all doses)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 33269793

Group type: EXPERIMENTAL
Intervention: Initial radiograph for Patient 1 (score 13)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Initial radiograph for Patient 2 (score 6)
Number of subjects: 2
Study: 32051822

Group type: EXPERIMENTAL
Intervention: 4 treatment sessions (group A)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 8 treatment sessions (group B)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 12 treatment sessions (group C)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Comparison between group A and group C
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Degree II nails
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Degree III nails
Number of subjects: 102
Study: 35720032

Group type: EXPERIMENTAL
Intervention: Olaparib combined with bevacizumab
Number of subjects: 84

Group type: COMPARATOR
Intervention: Albumin‐bound paclitaxel combined with bevacizumab
Number of subjects: 84
Study: 34736737

Group type: EXPERIMENTAL
Intervention: CGuard (MicroNet-covered stent)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Acculink (Conventional stent)
Number of subjects: 100
Study: 32070396

Group type: EXPERIMENTAL
Intervention: Multi-family therapy (MFT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic single-family therapy (SFT)
Number of subjects: 0
Study: 35299115

Group type: EXPERIMENTAL
Intervention: Dietary carob fruit (CF) supplementation (1 g/kg diet)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (0 g/kg diet)
Number of subjects: 32
Study: 32020852

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35953261

Group type: EXPERIMENTAL
Intervention: Pneumatic retinopexy (PnR)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Pars plana vitrectomy (PPV)
Number of subjects: 176
Study: 32275480

Group type: EXPERIMENTAL
Intervention: CAMS (n=33)
Number of subjects: 62

Group type: COMPARATOR
Intervention: TAU (n=29)
Number of subjects: 62
Study: 32320078

Group type: EXPERIMENTAL
Intervention: Combination therapy (CO2 laser treatment followed by three courses of oral traditional Chinese medicine)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (CO2 laser treatment only)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Combination therapy group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Cure group
Number of subjects: 160
Study: 35908167

Group type: EXPERIMENTAL
Intervention: Dexamethasone 24 mg
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 33605157

Group type: EXPERIMENTAL
Intervention: Mepilex Border Flex (MxBF)
Number of subjects: 51
Study: 32640124

Group type: EXPERIMENTAL
Intervention: Baloxavir
Number of subjects: 752

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 752
Study: 35508748

Group type: EXPERIMENTAL
Intervention: Intraperitoneal instillation of ropivacaine
Number of subjects: 104

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 104
Study: 34853625

Group type: EXPERIMENTAL
Intervention: ERAS protocol
Number of subjects: 179

Group type: COMPARATOR
Intervention: Routine nursing (non-ERAS)
Number of subjects: 179
Study: 33905751

Group type: EXPERIMENTAL
Intervention: Once-weekly exenatide (EQW)
Number of subjects: 14736

Group type: EXPERIMENTAL
Intervention: Enrollment in Latin America
Number of subjects: 14736

Group type: EXPERIMENTAL
Intervention: History of peripheral artery disease
Number of subjects: 14736

Group type: EXPERIMENTAL
Intervention: Enrollment in North America
Number of subjects: 14736

Group type: EXPERIMENTAL
Intervention: History of cardiovascular disease
Number of subjects: 14736

Group type: EXPERIMENTAL
Intervention: Previous myocardial infarction
Number of subjects: 14736
Study: 33255579

Group type: EXPERIMENTAL
Intervention: Labelling lower-energy density (ED) products as healthier choices
Number of subjects: 899

Group type: EXPERIMENTAL
Intervention: Increasing the proportion of lower-energy density (ED) products
Number of subjects: 899
Study: 33030703

Group type: EXPERIMENTAL
Intervention: Vericiguat 15 mg (single dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vericiguat 10 mg (once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vericiguat 2.5 mg (single or multiple doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vericiguat
Number of subjects: 0
Study: 34973039

Group type: COMPARATOR
Intervention: Prolonged exposure (PE) plus pill placebo (PE+PLB)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Sertraline plus enhanced medication management (SERT+EMM)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Prolonged exposure (PE) plus sertraline (PE+SERT)
Number of subjects: 176
Study: 32537238

Group type: EXPERIMENTAL
Intervention: Short term incentives (6 weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Long term incentives (12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No incentives (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Usual care smoking cessation treatment (counseling and nicotine replacement therapy)
Number of subjects: 60
Study: 33441772

Group type: EXPERIMENTAL
Intervention: High cut-off (HCO) dialysis
Number of subjects: 19

Group type: COMPARATOR
Intervention: High-flux (HFL) hemodialysis
Number of subjects: 19
Study: 32369032

Group type: EXPERIMENTAL
Intervention: Prostate Cancer Screening Preparation (PCSPrep)
Number of subjects: 41
Study: 33727066

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Doxycycline plus colchicine
Number of subjects: 5
Study: 32980656

Group type: EXPERIMENTAL
Intervention: Super Skills for Life (SSL) intervention group
Number of subjects: 100

Group type: COMPARATOR
Intervention: Waitlist-control (WLC) group
Number of subjects: 100
Study: 32500449

Group type: EXPERIMENTAL
Intervention: Mixed model for repeated measurements (MMRM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pattern-mixture model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Statistical methods for imputation
Number of subjects: 0
Study: 35090887

Group type: EXPERIMENTAL
Intervention: Electrical dry needling plus corticosteroid injection (electrical-DN+CSI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Corticosteroid injection (CSI)
Number of subjects: 60
Study: 32174207

Group type: EXPERIMENTAL
Intervention: PuraStatÂ®
Number of subjects: 20
Study: 35653294

Group type: EXPERIMENTAL
Intervention: High-risk group of obesity (miR-516-3p, miR-130a-3p)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Low-risk group of obesity (miR-1260b, miR-4709-3p, miR-194-3p)
Number of subjects: 38
Study: 33231614

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) dressing
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline dressing (control group)
Number of subjects: 60
Study: 32936795

Group type: EXPERIMENTAL
Intervention: Switch to second-line ART
Number of subjects: 80

Group type: COMPARATOR
Intervention: Continued first-line ART (control group)
Number of subjects: 80
Study: 36189591

Group type: EXPERIMENTAL
Intervention: PBM therapy
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 53
Study: 34530871

Group type: EXPERIMENTAL
Intervention: Machine learning algorithm for identifying patients who may benefit from palliative care review
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (standard care without the machine learning algorithm)
Number of subjects: 12
Study: 35458131

Group type: EXPERIMENTAL
Intervention: Multi-Ingredient Supplement (MS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Caffeine + Guarana (CAF + GUA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 24
Study: 33537776

Group type: EXPERIMENTAL
Intervention: Lipopolysaccharide (LPS) treatment (2.0 ng/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 20
Study: 34472596

Group type: EXPERIMENTAL
Intervention: aboBoNT‐A solution 50 U
Number of subjects: 0
Study: 33160636

Group type: EXPERIMENTAL
Intervention: Microfibrillar collagen hemostat
Number of subjects: 203

Group type: COMPARATOR
Intervention: No microfibrillar collagen hemostat
Number of subjects: 203
Study: 33109243

Group type: EXPERIMENTAL
Intervention: Medicinal plants (150 species)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Medicinal plants for digestive disorders
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Medicinal plants with 100% fidelity values
Number of subjects: 79

Group type: COMPARATOR
Intervention: Comparison of plant uses
Number of subjects: 79
Study: 33037580

Group type: EXPERIMENTAL
Intervention: Hydration with/without cinacalcet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol ablation of the parathyroid adenoma
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Normal vaginal delivery at term
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fetal outcomes
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Preeclampsia
Number of subjects: 8
Study: 32317470

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Inverted internal limiting membrane (ILM) flap
Number of subjects: 60
Study: 35237893

Group type: EXPERIMENTAL
Intervention: Astaxanthin (AST) 8 mg daily for 40 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35468827

Group type: EXPERIMENTAL
Intervention: Fathers' educational program (individual face-to-face education and counseling, 2 sessions, 40 min each, 1-week interval)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (no education for fathers, only mothers educated)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Fathers' educational program
Number of subjects: 76
Study: 34529963

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV (5×10^10 viral particles) on day 1 followed by MVA-BN-Filo (1×10^8 infectious units) on day 57
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV (5×10^10 viral particles) followed by MVA-BN-Filo
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV followed by MVA-BN-Filo
Number of subjects: 443

Group type: COMPARATOR
Intervention: MenACWY (first dose) followed by placebo (second dose)
Number of subjects: 443

Group type: COMPARATOR
Intervention: MenACWY
Number of subjects: 443
Study: 35858497

Group type: EXPERIMENTAL
Intervention: Primarily overt stuttering
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Primarily covert stuttering
Number of subjects: 21

Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 21
Study: 34493413

Group type: EXPERIMENTAL
Intervention: Predict Prostate tool
Number of subjects: 145

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 145
Study: 35501178

Group type: EXPERIMENTAL
Intervention: NVX-CoV2373 (5 μg SARS-CoV-2 rS; 50 μg Matrix-M1)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: NVX-CoV2373
Number of subjects: 200
Study: 33819703

Group type: EXPERIMENTAL
Intervention: Machine learning-based radiomic model using XGBoost
Number of subjects: 109

Group type: COMPARATOR
Intervention: Conventional MRI sequences (T1-W, T2-W, T2-FLAIR, post-contrast T1-W, ADC maps)
Number of subjects: 109
Study: 33164276

Group type: EXPERIMENTAL
Intervention: Emricasan (25 mg twice daily for 24 months)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Emricasan (25 mg twice daily for 24 months) in F3 to F5 subgroup
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo in F3 to F5 subgroup
Number of subjects: 64
Study: 32191001

Group type: EXPERIMENTAL
Intervention: Low intensity-shockwave therapy (Li-ESWT), 6 sessions over three weeks
Number of subjects: 118

Group type: COMPARATOR
Intervention: Diclofenac sodium suppositories
Number of subjects: 118
Study: 35759368

Group type: EXPERIMENTAL
Intervention: Nutrition + Exercise intervention (individualized high dairy protein diet and walking program)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Nutrition + Exercise intervention
Number of subjects: 203

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 203
Study: 34899419

Group type: EXPERIMENTAL
Intervention: Gamified AACTP smartphone application + treatment as usual (TAU)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Gamified AACTP sham-control application + TAU
Number of subjects: 317

Group type: COMPARATOR
Intervention: Only TAU
Number of subjects: 317
Study: 36173219

Group type: EXPERIMENTAL
Intervention: RASM
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: ASMI
Number of subjects: 63

Group type: COMPARATOR
Intervention: L3 SMI
Number of subjects: 63
Study: 33890388

Group type: EXPERIMENTAL
Intervention: Lurasidone 40 mg/day
Number of subjects: 483

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 483
Study: 32894140

Group type: EXPERIMENTAL
Intervention: Whey protein hydrolysate before and whey protein hydrolysate plus carbohydrate after each exercise session (PRO-CHO)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isocaloric carbohydrate supplements (CHO)
Number of subjects: 24
Study: 33339758

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation and transcranial direct current stimulation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vestibular rehabilitation alone
Number of subjects: 36
Study: 33487516

Group type: EXPERIMENTAL
Intervention: Opioid Court REACH intervention
Number of subjects: 0
Study: 35129580

Group type: EXPERIMENTAL
Intervention: Sleep extension group (individualized sleep hygiene counseling session to extend bedtime to 8.5 hours)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sleep extension group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (continued habitual sleep)
Number of subjects: 80
Study: 33663075

Group type: EXPERIMENTAL
Intervention: Buyang Huanwu decoction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33753535

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 33037200

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroid withdrawal
Number of subjects: 62
Study: 36380326

Group type: EXPERIMENTAL
Intervention: WeChat-group-based parental health education
Number of subjects: 365
Study: 33307024

Group type: COMPARATOR
Intervention: Control group (invitation to screening colonoscopy only)
Number of subjects: 12485

Group type: EXPERIMENTAL
Intervention: Sequential group (invitation to primary colonoscopy and invitation for FIT for initial nonresponders)
Number of subjects: 12485

Group type: EXPERIMENTAL
Intervention: Choice group (invitation offering a choice of colonoscopy or FIT)
Number of subjects: 12485

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12485

Group type: EXPERIMENTAL
Intervention: Sequential group
Number of subjects: 12485

Group type: EXPERIMENTAL
Intervention: Choice group
Number of subjects: 12485
Study: 32299386

Group type: EXPERIMENTAL
Intervention: Social concerns related to HIV status disclosure
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Older women (35-44 years)
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Concern about isolation or lack of support from family or friends
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Concern about separation
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Concern about conflict with a partner
Number of subjects: 437
Study: 36208314

Group type: EXPERIMENTAL
Intervention: 4.5/6 Fr semi-rigid ureteroscope
Number of subjects: 198

Group type: COMPARATOR
Intervention: 6/7.5 Fr semi-rigid ureteroscope
Number of subjects: 198
Study: 33145855

Group type: EXPERIMENTAL
Intervention: Extended lymph node dissection up to the level of the inferior mesenteric artery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lymph node dissection below the bifurcation of the common iliac artery
Number of subjects: 0
Study: 33735809

Group type: EXPERIMENTAL
Intervention: ipilimumab plus nivolumab
Number of subjects: 7
Study: 32393193

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training (HIIT)
Number of subjects: 60
Study: 36096864

Group type: EXPERIMENTAL
Intervention: CHO
Number of subjects: 400
Study: 34394935

Group type: EXPERIMENTAL
Intervention: Interval training (bicycle ergometric training, 6 times/week for 20 min during a 3-week program)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Continuous training (bicycle ergometric training, 6 times/week for 20 min during a 3-week program)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both interval and continuous training
Number of subjects: 120
Study: 35138335

Group type: EXPERIMENTAL
Intervention: Neoadjuvant ipilimumab plus nivolumab for 6 weeks
Number of subjects: 82
Study: 34033935

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with 150 µM methylene blue for 2 minutes and a 660 nm wavelength laser for 3 minutes (100 mW, 600 J/cm², total 18J)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (CG) without PDT application
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 70
Study: 33190149

Group type: EXPERIMENTAL
Intervention: Non-adherence to clinical trial protocol
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Participation in optional study DNA collection
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Participation in blood repository studies
Number of subjects: 1650
Study: 35878732

Group type: EXPERIMENTAL
Intervention: 30 g resistant starch (RS) daily
Number of subjects: 918

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 918